| Drug harms in the UK: a multicriteria decision analysis DJ Nutt, LA King, LD Phillips The Lancet 376 (9752), 1558-1565, 2010 | 2412 | 2010 |
| Development of a rational scale to assess the harm of drugs of potential misuse D Nutt, LA King, W Saulsbury, C Blakemore the Lancet 369 (9566), 1047-1053, 2007 | 1846 | 2007 |
| Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study RL Carhart-Harris, M Bolstridge, J Rucker, CMJ Day, D Erritzoe, M Kaelen, ... The Lancet Psychiatry 3 (7), 619-627, 2016 | 1694 | 2016 |
| Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function V Papadopoulos, M Baraldi, TR Guilarte, TB Knudsen, JJ Lacapère, ... Trends in pharmacological sciences 27 (8), 402-409, 2006 | 1619 | 2006 |
| Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin RL Carhart-Harris, D Erritzoe, T Williams, JM Stone, LJ Reed, A Colasanti, ... Proceedings of the National Academy of Sciences 109 (6), 2138-2143, 2012 | 1404 | 2012 |
| The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs RL Carhart-Harris, R Leech, PJ Hellyer, M Shanahan, A Feilding, ... Frontiers in human neuroscience 8, 55875, 2014 | 1360 | 2014 |
| Trial of psilocybin versus escitalopram for depression R Carhart-Harris, B Giribaldi, R Watts, M Baker-Jones, A Murphy-Beiner, ... New England Journal of Medicine 384 (15), 1402-1411, 2021 | 1080 | 2021 |
| Psilocybin with psychological support for treatment-resistant depression: six-month follow-up RL Carhart-Harris, M Bolstridge, CMJ Day, J Rucker, R Watts, DE Erritzoe, ... Psychopharmacology 235, 399-408, 2018 | 1032 | 2018 |
| Sleep disorders as core symptoms of depression D Nutt, S Wilson, L Paterson Dialogues in clinical neuroscience 10 (3), 329-336, 2008 | 996 | 2008 |
| Neural correlates of the LSD experience revealed by multimodal neuroimaging RL Carhart-Harris, S Muthukumaraswamy, L Roseman, M Kaelen, ... Proceedings of the National Academy of Sciences 113 (17), 4853-4858, 2016 | 962 | 2016 |
| Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the … DS Baldwin, IM Anderson, DJ Nutt, C Allgulander, B Bandelow, ... Journal of Psychopharmacology 28 (5), 403-439, 2014 | 812 | 2014 |
| Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology DS Baldwin, IM Anderson, DJ Nutt, B Bandelow, A Bond, JRT Davidson, ... Journal of Psychopharmacology 19 (6), 567-596, 2005 | 800 | 2005 |
| Serotonin and brain function: a tale of two receptors RL Carhart-Harris, DJ Nutt Journal of psychopharmacology 31 (9), 1091-1120, 2017 | 777 | 2017 |
| Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression L Roseman, DJ Nutt, RL Carhart-Harris Frontiers in pharmacology 8, 974, 2018 | 769 | 2018 |
| Amphetamine, past and present–a pharmacological and clinical perspective DJ Heal, SL Smith, J Gosden, DJ Nutt Journal of psychopharmacology 27 (6), 479-496, 2013 | 740 | 2013 |
| Homological scaffolds of brain functional networks G Petri, P Expert, F Turkheimer, R Carhart-Harris, D Nutt, PJ Hellyer, ... Journal of The Royal Society Interface 11 (101), 20140873, 2014 | 735 | 2014 |
| The dopamine theory of addiction: 40 years of highs and lows DJ Nutt, A Lingford-Hughes, D Erritzoe, PRA Stokes Nature Reviews Neuroscience 16 (5), 305-312, 2015 | 727 | 2015 |
| British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders SJ Wilson, DJ Nutt, C Alford, SV Argyropoulos, DS Baldwin, AN Bateson, ... Journal of psychopharmacology 24 (11), 1577-1601, 2010 | 675 | 2010 |
| Relationship of neurotransmitters to the symptoms of major depressive disorder DJ Nutt J Clin psychiatry 69 (Suppl E1), 4-7, 2008 | 674 | 2008 |
| Role of GABA in anxiety and depression AV Kalueff, DJ Nutt Depression and anxiety 24 (7), 495-517, 2007 | 643 | 2007 |
